Pharmaceutical Patent Analyst

0.4(top 50%)

impact factor

377(top 50%)

papers

2.3K(top 50%)

citations

21(top 50%)

h-index

0.9(top 50%)

impact factor

548

all documents

2.5K

doc citations

37(top 20%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Medicinal importance of gallic acid and its ester derivatives: a patent review	Pharmaceutical Patent Analyst	2015	204
2	Therapeutic charm of quercetin and its derivatives: a review of research and patents	Pharmaceutical Patent Analyst	2018	89
3	The A to Z of pharmaceutical cocrystals: a decade of fast-moving new science and patents	Pharmaceutical Patent Analyst	2012	84
4	Mangiferin: a promising anticancer bioactive	Pharmaceutical Patent Analyst	2016	68
5	Current trends in the development of wound dressings, biomaterials and devices	Pharmaceutical Patent Analyst	2013	59
6	Formulation strategies to improve oral peptide delivery	Pharmaceutical Patent Analyst	2014	56
7	Na⁺/K⁺-ATPase and cancer	Pharmaceutical Patent Analyst	2012	52
8	Pharmaceutical and biomedical applications of lipid-based nanocarriers	Pharmaceutical Patent Analyst	2014	52
9	Inhaled antibiotics to treat lung infection	Pharmaceutical Patent Analyst	2013	44
10	Small-molecule inhibitors of IκB kinase (IKK) and IKK-related kinases	Pharmaceutical Patent Analyst	2013	43
11	Transient receptor potential ankyrin 1 (TRPA1) antagonists	Pharmaceutical Patent Analyst	2015	42
12	Inhibitors of voltage-gated sodium channel Na_v1.7: patent applications since 2010	Pharmaceutical Patent Analyst	2014	37
13	Inhibitors of emerging epigenetic targets for cancer therapy: a patent review (2010–2014)	Pharmaceutical Patent Analyst	2015	36
14	Small-molecule arginase inhibitors	Pharmaceutical Patent Analyst	2014	35
15	Celastrol as a pentacyclic triterpenoid with chemopreventive properties	Pharmaceutical Patent Analyst	2018	34
16	Lipid-based nanocarriers for drug delivery and targeting: a patent survey of methods of production and characterization	Pharmaceutical Patent Analyst	2013	33
17	Targeting inflammation: multiple innovative ways to reduce prostaglandin E2	Pharmaceutical Patent Analyst	2013	31
18	P2X7 antagonists for CNS indications: recent patent disclosures	Pharmaceutical Patent Analyst	2017	27
19	Toward isozyme-selective inhibitors of histone deacetylase as therapeutic agents for the treatment of cancer	Pharmaceutical Patent Analyst	2012	25
20	Metabotropic glutamate receptor 5-positive allosteric modulators for the treatment of schizophrenia (2004–2012)	Pharmaceutical Patent Analyst	2013	25
21	Recent advances in vaccine delivery	Pharmaceutical Patent Analyst	2016	24
22	Pharmacological chaperones for enzyme enhancement therapy in genetic diseases	Pharmaceutical Patent Analyst	2013	23
23	PDK1 inhibitors	Pharmaceutical Patent Analyst	2012	22
24	Approaches targeting the FGF–FGFR system: a review of the recent patent literature and associated advanced therapeutic agents	Pharmaceutical Patent Analyst	2014	22
25	Monoclonal antibodies based on hybridoma technology	Pharmaceutical Patent Analyst	2013	20
26	SGLT inhibitors: a novel target for diabetes	Pharmaceutical Patent Analyst	2013	20
27	Humira: the impending patent battles over adalimumab biosimilars	Pharmaceutical Patent Analyst	2016	20
28	Current patent and clinical status of stimulator of interferon genes (STING) agonists for cancer immunotherapy	Pharmaceutical Patent Analyst	2019	20
29	Antibody–drug conjugates in tumor therapy	Pharmaceutical Patent Analyst	2012	19
30	Current trends in the development of histone deacetylase inhibitors: a review of recent patent applications	Pharmaceutical Patent Analyst	2012	19
31	Advances in recent patent and clinical trial drug development for Alzheimer’s disease	Pharmaceutical Patent Analyst	2014	19
32	Oral insulin-delivery system for diabetes mellitus	Pharmaceutical Patent Analyst	2015	18
33	Novel platinum compounds and nanoparticles as anticancer agents	Pharmaceutical Patent Analyst	2018	18
34	Selective and nonselective HDAC8 inhibitors: a therapeutic patent review	Pharmaceutical Patent Analyst	2018	17
35	Integrated continuous manufacturing in pharmaceutical industry: current evolutionary steps toward revolutionary future	Pharmaceutical Patent Analyst	2019	17
36	Toward selective TYK2 inhibitors as therapeutic agents for the treatment of inflammatory diseases	Pharmaceutical Patent Analyst	2014	16
37	Novel treatment strategies for brain tumors and metastases	Pharmaceutical Patent Analyst	2014	16
38	Recent advances in irreversible kinase inhibitors	Pharmaceutical Patent Analyst	2014	16
39	Glucokinase activators	Pharmaceutical Patent Analyst	2012	15
40	Nanocoatings on implantable medical devices	Pharmaceutical Patent Analyst	2013	15
41	Metabotropic glutamate receptor 5-negative allosteric modulators for the treatment of psychiatric and neurological disorders (2009–July 2013)	Pharmaceutical Patent Analyst	2013	15
42	ENaC inhibitors for the treatment of cystic fibrosis	Pharmaceutical Patent Analyst	2015	15
43	Novel drug therapies in myeloid leukemia: a patent review	Pharmaceutical Patent Analyst	2015	15
44	Toward carbon monoxide based therapeutics: carbon monoxide in a pill	Pharmaceutical Patent Analyst	2017	15
45	Ca²⁺ release-activated Ca²⁺ channel inhibitors	Pharmaceutical Patent Analyst	2014	14
46	Baicalein: promising therapeutic applications with special reference to published patents	Pharmaceutical Patent Analyst	2022	14
47	The impact of effective patents on future innovations in nanomedicine	Pharmaceutical Patent Analyst	2012	13
48	Small-molecule antagonists of the orexin receptors	Pharmaceutical Patent Analyst	2014	13
49	A comprehensive review of patented antileishmanial agents	Pharmaceutical Patent Analyst	2015	13
50	Fluorine-18 patents (2009–2015). Part 2: new radiochemistry	Pharmaceutical Patent Analyst	2016	13

Scientometrics

Overviews

Citing Bodies

Pharmaceutical Patent Analyst

Top Articles